Bilcare Ltd

₹ 53.8 -1.14%

26 Jul - close price

About

Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).

Key Points

Products & Services offered:
a) Pharma Packaging:^[1]
Pharma Packaging is available in two broad categories viz., Polymer based Packaging Films and Aluminum based Packaging Foils. Their sub-categories are:
Blister Films
Blister Foils
Lidding Foils
CR Foils
Laminates
b) Global Clinical Supplies and Services:^[2]
Company handles domestic and global manufacturing of IMPs and Placebos, Primary
and secondary packaging with various blinding techniques, IWRS, Storage at variable temperatures.

Website BSE

Market Cap ₹ 127 Cr.
Current Price ₹ 53.8
High / Low ₹ 95.4 / 51.0
Stock P/E
Book Value ₹ 211
Dividend Yield 0.00 %
ROCE 1.22 %
ROE -5.73 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.25 times its book value

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -24.3% over past five years.
Promoter holding is low: 30.0%
Company has a low return on equity of -8.16% over last 3 years.
Contingent liabilities of Rs.45.1 Cr.
Earnings include an other income of Rs.15.9 Cr.
Working capital days have increased from 69.2 days to 115 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Packaging Industry: Packaging

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	176	178	204	208	256	248	254	246	234	182	190	175	200
	165	165	188	194	237	232	240	234	219	169	173	158	208
Operating Profit	10	12	16	13	19	16	14	12	14	13	17	17	-8
OPM %	6%	7%	8%	6%	7%	6%	6%	5%	6%	7%	9%	10%	-4%
	38	4	34	0	5	3	10	-6	231	3	1	4	9
Interest	21	18	18	16	17	16	16	16	11	19	20	21	23
Depreciation	12	11	9	10	9	9	9	10	9	10	10	11	13
Profit before tax	15	-13	23	-12	-3	-7	-2	-20	225	-13	-13	-10	-35
Tax %	0%	0%	-3%	-2%	38%	-11%	60%	-6%	65%	-1%	-5%	34%	-44%
	15	-13	23	-11	-3	-6	-3	-19	78	-13	-12	-14	-20
EPS in Rs	4.97	-6.49	9.51	-5.90	-2.48	-2.84	-2.42	-7.98	19.63	-3.36	-3.22	-2.91	-4.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	3,547	3,062	2,692	2,603	2,633	2,778	2,997	1,827	623	845	982	747
	3,159	2,819	2,506	2,396	2,443	2,617	2,827	1,782	572	784	925	708
Operating Profit	387	243	186	207	190	161	170	45	51	60	57	39
OPM %	11%	8%	7%	8%	7%	6%	6%	2%	8%	7%	6%	5%
	-8	24	9	-87	107	297	59	254	45	44	237	16
Interest	167	217	236	151	176	249	283	174	76	69	60	82
Depreciation	148	141	191	164	177	416	378	239	46	39	38	45
Profit before tax	63	-91	-232	-194	-56	-207	-433	-114	-25	-4	196	-72
Tax %	30%	25%	-7%	-58%	42%	-4%	5%	-13%	-55%	3%	74%	-18%
	44	-114	-216	-82	-80	-199	-453	-99	-11	-4	50	-59
EPS in Rs	16.81	-48.14	-91.76	-36.04	-35.91	-85.43	-193.28	-43.97	-8.95	-5.35	6.39	-14.11
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%	-0%

Compounded Sales Growth
10 Years:	-13%
5 Years:	-24%
3 Years:	6%
TTM:	-24%

Compounded Profit Growth
10 Years:	6%
5 Years:	14%
3 Years:	3%
TTM:	-213%

Stock Price CAGR
10 Years:	-6%
5 Years:	22%
3 Years:	-19%
1 Year:	-27%

Return on Equity
10 Years:	-35%
5 Years:	-39%
3 Years:	-8%
Last Year:	-6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	24	24	24	24	24	24	24	24	24	24	24	24
Reserves	1,302	1,300	1,073	689	590	376	-93	85	63	52	507	474
	2,104	2,146	2,311	2,122	2,014	2,089	2,270	707	677	690	639	756
	971	899	933	786	830	913	888	297	300	362	418	314
Total Liabilities	4,400	4,368	4,340	3,620	3,457	3,402	3,087	1,112	1,064	1,127	1,588	1,568
	1,493	2,126	1,926	2,432	2,403	2,180	2,005	534	494	465	1,045	1,039
CWIP	846	262	218	161	149	170	79	0	0	1	1	1
Investments	0	0	0	1	0	1	0	0	0	0	2	8
	2,061	1,979	2,196	1,026	904	1,051	1,003	577	570	661	539	521
Total Assets	4,400	4,368	4,340	3,620	3,457	3,402	3,087	1,112	1,064	1,127	1,588	1,568

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	227	314	-315	177	300	98	206	256	72	41	-7	62
	-966	-351	247	-358	-129	-203	-104	1,309	2	-4	36	-106
	661	48	119	149	-155	91	-103	-1,600	-83	-55	-19	36
Net Cash Flow	-78	12	50	-32	16	-13	-1	-35	-9	-18	10	-7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	106	105	125	35	29	38	38	22	90	95	70	73
Inventory Days	80	103	105	108	84	90	82	28	90	83	43	77
Days Payable	90	76	93	86	81	102	71	35	93	102	79	70
Cash Conversion Cycle	95	132	137	57	32	25	49	15	88	76	33	80
Working Capital Days	130	145	156	35	16	24	28	27	67	57	36	115
ROCE %	8%	3%	1%	2%	2%	-8%	-6%	-9%	3%	3%	3%	1%

Shareholding Pattern

Numbers in percentages

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%
	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
	69.94%	69.94%	69.95%	69.94%	69.94%	69.95%	69.95%	69.95%	69.94%	69.95%	69.95%	69.95%
No. of Shareholders	21,870	21,928	22,322	23,158	23,236	23,419	22,322	21,691	19,875	19,181	19,116	18,783

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Jun 2024
	32.97%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%	30.01%
	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%
	66.99%	69.94%	69.94%	69.94%	69.94%	69.95%	69.95%	69.95%	69.95%
No. of Shareholders	18,141	17,008	16,530	15,827	20,017	22,322	22,322	19,116	18,783

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Bilcare Ltd

Bilcare Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings